[
  {
    "ts": "2026-03-01T04:50:00+00:00",
    "headline": "Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement",
    "summary": "Bristol Myers Squibb has an attractive 4% yield and a strong dividend history.",
    "url": "https://www.fool.com/investing/2026/02/28/this-big-pharma-dividend-bmy-could-help-turn-10000/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f009b306-0cc4-3536-b230-0ae8d01096f4",
      "content": {
        "id": "f009b306-0cc4-3536-b230-0ae8d01096f4",
        "contentType": "STORY",
        "title": "Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement",
        "description": "",
        "summary": "Bristol Myers Squibb has an attractive 4% yield and a strong dividend history.",
        "pubDate": "2026-03-01T04:50:00Z",
        "displayTime": "2026-03-01T04:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/8b1923716232d237a71d4617817a9562",
          "originalWidth": 1400,
          "originalHeight": 875,
          "caption": "A piggy bank standing behind stacks of coins, one of which is growing a green seedling.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vhJaQ3w33rbCjO7bLF.nXg--~B/aD04NzU7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/8b1923716232d237a71d4617817a9562.cf.webp",
              "width": 1400,
              "height": 875,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AkalUv1xEGJ98_KYx9f73Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/8b1923716232d237a71d4617817a9562.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/28/this-big-pharma-dividend-bmy-could-help-turn-10000/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/big-pharma-dividend-stock-bmy-045000912.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-03-01T14:11:18+00:00",
    "headline": "What Bristol-Myers Squibb (BMY)'s Triple-Negative Breast Cancer Phase III Survival Win Means For Shareholders",
    "summary": "In late February 2026, Bristol Myers Squibb and partner SystImmune reported that antibody-drug conjugate izalontamab brengitecan (iza-bren) achieved statistically significant, clinically meaningful improvements in both progression-free and overall survival versus chemotherapy in a Phase III trial for previously treated unresectable locally advanced or metastatic triple-negative breast cancer. This marks the third successful pivotal study for iza-bren and the first bispecific antibody-drug...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-triple-141118353.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4d1f3dff-8321-3f28-a56f-fdbf17ac875e",
      "content": {
        "id": "4d1f3dff-8321-3f28-a56f-fdbf17ac875e",
        "contentType": "STORY",
        "title": "What Bristol-Myers Squibb (BMY)'s Triple-Negative Breast Cancer Phase III Survival Win Means For Shareholders",
        "description": "",
        "summary": "In late February 2026, Bristol Myers Squibb and partner SystImmune reported that antibody-drug conjugate izalontamab brengitecan (iza-bren) achieved statistically significant, clinically meaningful improvements in both progression-free and overall survival versus chemotherapy in a Phase III trial for previously treated unresectable locally advanced or metastatic triple-negative breast cancer. This marks the third successful pivotal study for iza-bren and the first bispecific antibody-drug...",
        "pubDate": "2026-03-01T14:11:18Z",
        "displayTime": "2026-03-01T14:11:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-triple-141118353.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-triple-141118353.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]